Covalent fragment screening and optimization identifies the chloroacetohydrazide scaffold as inhibitors for ubiquitin C-terminal hydrolase L1
Dysregulation of the ubiquitin-proteasome systems is a hallmark of various disease states including neurodegenerative diseases and cancer. Ubiquitin C-terminal hydrolase L1 (UCHL1), a deubiquitinating enzyme, is expressed primarily in the central nervous system under normal physiological conditions,...
Auteurs principaux: | Imhoff, RD, Patel, R, Safdar, MH, Jones, HBL, Pinto-Fernandez, A, Vendrell, I, Chen, H, Muli, CS, Krabill, AD, Kessler, BM, Wendt, MK, Das, C, Flaherty, DP |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
American Chemical Society
2024
|
Documents similaires
-
Structural dynamics of the ubiquitin specific protease UPS30 in complex with a cyanopyrrolidine-containing covalent inhibitor
par: O’Brien, DP, et autres
Publié: (2024) -
Specific and covalent targeting of conjugating and deconjugating enzymes of ubiquitin-like proteins
par: Hemelaar, J, et autres
Publié: (2004) -
DUB esterase activity further decodes ubiquitin’s enigma
par: Kessler, BM
Publié: (2021) -
Probing the ubiquitin landscape
par: Mulder, M, et autres
Publié: (2020) -
Elevated cerebrospinal fluid ubiquitin carboxyl-terminal hydrolase isozyme L1 in asymptomatic C9orf72 hexanucleotide repeat expansion carriers
par: Dellar, ER, et autres
Publié: (2024)